This excerpt taken from the EYE 8-K filed Dec 5, 2007.
G. MASON MORFIT TO BOARD OF DIRECTORS
SANTA ANA, CA (December 5, 2007) Advanced Medical Optics, Inc. (AMO) [NYSE: EYE], a global leader in ophthalmic surgical devices and eye care products, today announced the election of Daniel J. Heinrich and G. Mason Morfit to its board of directors, increasing the companys board to 10 members.
Since 2003, Mr. Heinrich, 51, has been senior vice president and chief financial officer of The Clorox Company [NYSE: CLX], the global consumer packaged goods company with approximately $4.8 billion in annual sales and more than 7,800 employees worldwide. Mr. Morfit, 32, is a partner at San Francisco-based ValueAct Capital Partners, a private investment partnership with more than $6 billion in assets under management on behalf of some of the worlds most respected institutional and high-net worth investors. ValueAct Capital is AMOs largest stockholder.
Dan and Mason each bring distinct experiences that will broaden and enrich our board, said Jim Mazzo, chairman and chief executive officer. Dans extensive financial expertise and understanding of the global consumer market will be immensely valuable as we execute our complete refractive solution strategy. Mason brings the perspective of a major stockholder with demonstrated governance and capital markets expertise. We are pleased to welcome both gentlemen as new directors and look forward to their contributions.
In his current position, Mr. Heinrich serves as a key member of Cloroxs executive committee, working closely with that companys board and its committees in establishing financial strategies and targets, reviewing financial and operating performance, ensuring appropriate corporate governance, working closely with the investment community and ensuring strong financial discipline and internal controls. From 2001 to 2003, he served as controller and chief accounting officer for Clorox. His prior experience includes senior-level financial positions with Transamerica Corp., Ford Motor Companys Financial Services Group and Ernst & Young. A certified public accountant, Mr. Heinrich holds an MBA from St. Marys College and a bachelors degree from the University of California, Berkeley. Mr. Heinrichs term on AMOs board will expire at the 2010 Annual Stockholders Meeting. He will serve on the AMO boards audit and finance committee.
Mr. Morfit currently serves on the boards of directors of MSD Performance, Inc. and Valeant Pharmaceuticals International, Inc. [NYSE: VRX], and he is a former director of Solexa, Inc. A chartered financial analyst, he holds a bachelors degree from Princeton University. Mr. Morfits term on AMOs board will expire at the 2009 Annual Stockholders Meeting and he will serve on the boards science and technology committee.